Higher plasma DPP4 (Dipeptidyl Peptidase 4) can be found among patients with obesity, metabolic syndrome, and DM, who are at risk of a severe course of COVID-19 [79]. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.